Optogenerapy project has been presented during the Organic and Printed Electronics Association (OE-A) 44th Working Group Meeting, which has taken place in Aix-en-Provence, France, on October 23-24.
Moha Mashayekhi, researcher at Eurecat, has given a presentation on Optogenerapy‘s optoelectronics module during the networking coffee on publicly funded projects. In addition, the poster “Bio-electronic Cell Based Implant for Multiple Sclerosis Protein Therapy” has been exhibited.
Optogenerapy medical device consists on a drug delivery cell chamber and an optoelectronics module, a micro-power energy harvesting antenna and rectifying circuit controlling a NIR-LED which will trigger the generation and delivery of beta interferon (IFN- ß) drug for treating patients suffering from Multiple Sclerosis.
To develop the electronics, Optogenerapy partners developed flexible compact low-resistance screen-printed Near Field Communication (NFC) antennaswith high quality factor, as well as the footprint and interconnections, on which the components are hybridized.
The use of NFC technology enables the exchange of data between two devices and allows smaller Q factor antennas than the ones made by Printed Circuit Board (PCB) technologies. The flexibility and miniaturization of the tag antenna play an important role in implants, packaging, and payment applications.
The Organic and Printed Electronics Association (OE-A) Europe aims at promoting information exchange among all players along the organic and printed electronics value chain and provide its members with networking and communication platforms.